Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

View source ↗

Summary

A real-world effectiveness study to evaluate belimumab for adults with lupus nephritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lupus Nephritis | Status: RECRUITING